{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:09:31Z","timestamp":1793210971005,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jaci.2005.09.051","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:25:05Z","timestamp":1139405105000},"page":"S435-S441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"S2","title":["2. Update on primary immunodeficiency diseases"],"prefix":"10.1016","volume":"117","author":[{"given":"Francisco A.","family":"Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raif S.","family":"Geha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.jaci.2005.09.051_bib1","doi-asserted-by":"crossref","first-page":"S571","DOI":"10.1067\/mai.2003.86","article-title":"Primary immunodeficiency diseases","volume":"111","author":"Bonilla","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2005.09.051_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib3","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1172\/JCI18937","article-title":"A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans","volume":"112","author":"Sawada","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2005.09.051_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(04)00332-1","article-title":"LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins","volume":"564","author":"Kubota","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2005.09.051_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B-cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2005.09.051_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni974","article-title":"Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination","volume":"4","author":"Imai","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tig.2005.02.013","article-title":"The contested role of uracil DNA glycosylase in immunoglobulin gene diversification","volume":"21","author":"Longerich","year":"2005","journal-title":"Trends Genet"},{"key":"10.1016\/j.jaci.2005.09.051_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2005.00222.x","article-title":"Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects","volume":"203","author":"Durandy","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2005.09.051_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","article-title":"Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features","volume":"203","author":"Lougaris","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2005.09.051_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clim.2004.07.002","article-title":"ICOS deficiency in patients with common variable immunodeficiency","volume":"113","author":"Salzer","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2005.09.051_bib12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2005.09.051_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2005.09.051_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/clim.2001.5024","article-title":"A case of x-linked agammaglobulinemia diagnosed in adulthood","volume":"99","author":"Stewart","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2249.2000.01244.x","article-title":"Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry","volume":"120","author":"Kanegane","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood.V98.5.1321","article-title":"Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome","volume":"98","author":"Morra","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2005.09.051_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clim.2003.12.005","article-title":"IgA deficiency: clinical correlates and responses to pneumococcal vaccine","volume":"111","author":"Edwards","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1521-6616(03)00201-8","article-title":"The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease","volume":"109","author":"Ehrlich","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib19","first-page":"379","article-title":"The ICF syndrome: new case and update","volume":"12","author":"De Ravel","year":"2001","journal-title":"Genet Couns"},{"key":"10.1016\/j.jaci.2005.09.051_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00431-003-1375-8","article-title":"Idiopathic CD4+ T-lymphocytopenia in a boy with Down syndrome. Report of a patient and a review of the literature","volume":"163","author":"Tanaka","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaci.2005.09.051_bib21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S1286-4579(02)00038-2","article-title":"Human natural killer cell deficiencies and susceptibility to infection","volume":"4","author":"Orange","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jaci.2005.09.051_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V99.5.1723","article-title":"Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells","volume":"99","author":"Vitale","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2005.09.051_bib23","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI0214858","article-title":"Deficient natural killer cell cytotoxicity in patients with IKK-\u03b3\/NEMO mutations","volume":"109","author":"Orange","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2005.09.051_bib24","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa031178","article-title":"Effect of CD3\u03b4 deficiency on maturation of \u03b1\/\u03b2 and \u03b3\/\u03b4 T-cell lineages in severe combined immunodeficiency","volume":"349","author":"Dadi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2005.09.051_bib25","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood-2001-12-0252","article-title":"A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination","volume":"100","author":"Yabe","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2005.09.051_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/35065105","article-title":"Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice","volume":"410","author":"Lindsay","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2005.09.051_bib27","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(03)14632-6","article-title":"Role of TBX1 in human del22q11.2 syndrome","volume":"362","author":"Yagi","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2005.09.051_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2002-08-2545","article-title":"Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients","volume":"102","author":"Markert","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2005.09.051_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1067\/mai.2003.165","article-title":"Long-term assessment of T-cell populations in DiGeorge syndrome","volume":"111","author":"Chinen","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib30","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1542\/peds.112.4.e325","article-title":"Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"112","author":"Perez","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2005.09.051_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clim.2004.02.008","article-title":"Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity","volume":"112","author":"Moylett","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib32","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1182\/blood-2003-08-2984","article-title":"Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome","volume":"104","author":"Markert","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2005.09.051_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s100240010171","article-title":"Omenn's syndrome: differential diagnosis in infants with erythroderma and immunodeficiency","volume":"4","author":"Scheimberg","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jaci.2005.09.051_bib34","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2004-12-4861","article-title":"Omenn syndrome due to ARTEMIS mutations","volume":"105","author":"Ege","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2005.09.051_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0105-2896.2005.00221.x","article-title":"Human disease resulting from gene mutations that interfere with appropriate nuclear factor-\u03baB activation","volume":"203","author":"Orange","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2005.09.051_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0105-2896.2005.00235.x","article-title":"Inherited disorders of human Toll-like receptor signaling: immunological implications","volume":"203","author":"Ku","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2005.09.051_bib37","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI18714","article-title":"A hypermorphic I\u03baB\u03b1 mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency","volume":"112","author":"Courtois","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2005.09.051_bib38","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2004.06.052","article-title":"Human nuclear factor \u03baB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia","volume":"114","author":"Orange","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib39","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jaci.2004.08.047","article-title":"Nuclear factor \u03baB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia","volume":"114","author":"Niehues","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2005.09.051_bib40","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2005.09.051_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2005.09.051_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0105-2896.2005.00226.x","article-title":"CXCR4 mutations in WHIM syndrome: a misguided immune system?","volume":"203","author":"Diaz","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2005.09.051_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cellbi.2005.04.001","article-title":"Pathways to caspase activation","volume":"29","author":"Wang","year":"2005","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jaci.2005.09.051_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature01063","article-title":"Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2005.09.051_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/shem.2002.31913","article-title":"Kostmann syndrome and severe congenital neutropenia","volume":"39","author":"Zeidler","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jaci.2005.09.051_bib46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/85886","article-title":"Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia","volume":"27","author":"Devriendt","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2005.09.051_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","article-title":"Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity","volume":"144","author":"Renner","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2005.09.051_bib48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","article-title":"Hyper-IgE syndromes","volume":"203","author":"Grimbacher","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2005.09.051_bib49","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2005.09.051_bib50","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2005.09.051_bib51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/434127b","article-title":"Gene-therapy trials to restart following cancer risk review","volume":"434","author":"Check","year":"2005","journal-title":"Nature"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674905022657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674905022657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:03:19Z","timestamp":1758776599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674905022657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0091674905022657"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2005.09.051","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2. Update on primary immunodeficiency diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2005.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}